Pure velocity SUNSCREEN SPF 50 1.5 g/100g
ETHYLHEXYL METHOXYCINNAMATE,ZINC OXIDE · LIQUID · Guangzhou Haishi Biological Technology Co., Ltd.
Pure velocity SUNSCREEN SPF 50 is a liquid containing ethylhexyl methoxycinnamate,zinc oxide at 1.5 g/100g, taken topical. Manufactured by Guangzhou Haishi Biological Technology Co., Ltd..
Key Facts
- Brand Name
- Pure velocity SUNSCREEN SPF 50
- Generic Name
- ETHYLHEXYL METHOXYCINNAMATE,ZINC OXIDE
- NDC Code (Product)
60771-0031- Manufacturer
- Guangzhou Haishi Biological Technology Co., Ltd.
- Strength
- 1.5 g/100g
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 09/30/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses If used as directed with other sun protection measures(see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Dosage & Administration
Dosage & administration Squeeze out an appropriate amount of Sunscreen and spread evenly on skin.
Warnings
Warnings For external use only
Frequently Asked Questions
What is Pure velocity SUNSCREEN SPF 50 used for?
Pure velocity SUNSCREEN SPF 50 contains ETHYLHEXYL METHOXYCINNAMATE,ZINC OXIDE. It is a liquid taken topical. Consult your doctor for specific uses.
Is Pure velocity SUNSCREEN SPF 50 a controlled substance?
Pure velocity SUNSCREEN SPF 50 is not classified as a controlled substance by the DEA.
What is the generic name for Pure velocity SUNSCREEN SPF 50?
The generic name for Pure velocity SUNSCREEN SPF 50 is ETHYLHEXYL METHOXYCINNAMATE,ZINC OXIDE. There are no other listed brand versions of ETHYLHEXYL METHOXYCINNAMATE,ZINC OXIDE.
What is the NDC code for Pure velocity SUNSCREEN SPF 50 1.5 g/100g?
The NDC (National Drug Code) for Pure velocity SUNSCREEN SPF 50 1.5 g/100g is 60771-0031, listed by Guangzhou Haishi Biological Technology Co., Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)